Lingjuan Liu
-
- Cardiomyopathy and Myosin Studies 4
- Cardiac Fibrosis and Remodeling 4
-
- Tea Polyphenols and Effects 4
-
- Congenital Heart Disease Studies 4
-
- Congenital heart defects research 3
-
- Coronary Artery Anomalies 3
-
- Tissue Engineering and Regenerative Medicine 2
-
- GDF15 and Related Biomarkers 2
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)Frontiers in Pediatrics (2 papers)Genes & Diseases (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Lingjuan Liu
24 papers receiving 390 citations
Peers
Comparison fields: 5 of 97
- Geriatrics and Gerontology 16
- Genetics 40
- Biochemistry 21
- Cardiology and Cardiovascular Medicine 75
- Biological Psychiatry 7
Countries citing papers authored by Lingjuan Liu
This map shows the geographic impact of Lingjuan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjuan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjuan Liu more than expected).
Fields of papers citing papers by Lingjuan Liu
This network shows the impact of papers produced by Lingjuan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjuan Liu. The network helps show where Lingjuan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingjuan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 0 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 30 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 24 | |
| 15 | 2018 | 11 | |
| 16 | 2018 | 21 | |
| 17 | 2017 | 59 | |
| 18 | 2017 | 10 | |
| 19 | 2015 | 25 | |
| 20 | 2014 | 20 |
About Lingjuan Liu
Lingjuan Liu is a scholar working on Health Informatics, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine, having authored 32 papers that have together received 392 indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (4 papers), Tea Polyphenols and Effects (4 papers), Congenital Heart Disease Studies (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Congenital heart defects research (3 papers), Coronary Artery Anomalies (3 papers), Tissue Engineering and Regenerative Medicine (2 papers) and GDF15 and Related Biomarkers (2 papers). The work is most often cited by research in Geriatrics and Gerontology (16 citations), Genetics (40 citations) and Biochemistry (21 citations). Lingjuan Liu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Xupei Huang, Jie Tian, Jing Zhu, Bo Pan, Jie Tian, Tiewei Lv, Weian Zhao, Xing Shen, Huiming Zhou and Danfeng Zhang. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Frontiers in Pediatrics, Genes & Diseases, Journal of Biomedical Science and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.